Publications by authors named "Timothy Illidge"

Claim this Profile
E
Efficacy and toxicity of hypofractionated radiation therapy for patients with hematologic malignancies: A COVID-era ILROG collaborative report.
Jillian R Gunther, Joanna C Yang, Carla Hajj, Andrea K Ng, Jessica L Brady, Timothy M Illidge

Radiother Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCR2-driven monocyte recruitment is protective against radiotherapy-induced intestinal toxicity.
Nabina Pun, Urszula M Cytlak, Dave Lee, Rita G Domingues, Eleanor J Cheadle, Timothy M Illidge

Mucosal Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large B-cell lymphoma (LBCL): EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up.
Catherine Thieblemont, Maria Gomes Da Silva, Sirpa Leppä, Georg Lenz, Anne-Ségolène Cottereau, Timothy Illidge

Hemasphere· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe.
Florence Broussais, Elise Pennings, Natacha Bolanos, Lorna Warwick, Robin Doeswijk, Timothy Illidge

Hemasphere· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of relapsed or refractory large B-cell lymphoma: A British Society for Haematology Guideline.
Sridhar Chaganti, Christopher P Fox, Bernard D Maybury, Cathy Burton, Sally F Barrington, Timothy Illidge

Br J Haematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The management of newly diagnosed large B-cell lymphoma: A British Society for Haematology Guideline.
Christopher P Fox, Sridhar Chaganti, Graham McIlroy, Sally F Barrington, Cathy Burton, Timothy Illidge

Br J Haematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective Chart Review of Treatment Patterns and Overall Survival among a Cohort of Patients with Relapsed/Refractory Mycosis Fungoides in France, Germany, Italy, Spain and the United Kingdom.
Chalid Assaf, Timothy M Illidge, Nathalie Waser, Mary He, Tina Li

Cancers (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies.
Ester Fagnano, Swati Pendharkar, Madyson Colton, Philip N Jones, Marta Crespi Sallan, Timothy M Illidge

Front Cell Dev Biol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia Is Associated with Increased Immune Infiltrates and Both Anti-Tumour and Immune Suppressive Signalling in Muscle-Invasive Bladder Cancer.
Vicky Smith, Dave Lee, Mark Reardon, Rekaya Shabbir, Sudhakar Sahoo, Timothy Illidge

Int J Mol Sci· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse patterns in early-PET negative, limited-stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy-a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trials.
Valeria Fiaccadori, Anouk Neven, Catherine Fortpied, Igor Aurer, Marc Andre, Timothy Illidge

Br J Haematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer.
Vicky Smith, Debayan Mukherjee, Anna Maria Tsakiroglou, Alexander Baker, Hitesh Mistry, Timothy Illidge

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulation by radiotherapy in tumour control and normal tissue toxicity.
Urszula M Cytlak, Douglas P Dyer, Jamie Honeychurch, Kaye J Williams, Mark A Travis, Timothy M Illidge

Nat Rev Immunol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary Treatment Patterns and Response in Relapsed/Refractory Cutaneous T-Cell Lymphoma (CTCL) across Five European Countries.
Chalid Assaf, Nathalie Waser, Martine Bagot, Mary He, Tina Li, Timothy M Illidge

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of DNA-PK with AZD7648 Sensitizes Tumor Cells to Radiotherapy and Induces Type I IFN-Dependent Durable Tumor Control.
Kyoko Nakamura, Ankur Karmokar, Paul M Farrington, Neil H James, Antonio Ramos-Montoya, Timothy M Illidge

Clin Cancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre Cohort.
Nicolas Martinez-Calle, Amy A Kirkwood, Maxine Lamb, Alex Smith, Jahanzaib Khwaja, Timothy Illidge

Adv Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy-Immunotherapy Combination: How Will We Bridge the Gap Between Pre-Clinical Promise and Effective Clinical Delivery?
Erminia Romano, Jamie Honeychurch, Timothy M Illidge

Cancers (Basel)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-Like Receptor Agonists and Radiation Therapy Combinations: An Untapped Opportunity to Induce Anticancer Immunity and Improve Tumor control.
Richard C Walshaw, Jamie Honeychurch, Ananya Choudhury, Timothy M Illidge

Int J Radiat Oncol Biol Phys· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating Radiotherapy Response in a Novel Syngeneic Model of Prostate Cancer.
Charles M Haughey, Debayan Mukherjee, Rebecca E Steele, Amy Popple, Lara Dura-Perez, Timothy Illidge

Cancers (Basel)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the Effects of Radiotherapy on the Tumour Immune Microenvironment to Identify Potential Prognostic and Predictive Biomarkers of Radiotherapy Response.
Shuhui Cheng, Eleanor J Cheadle, Timothy M Illidge

Cancers (Basel)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scientific rationale underpinning the development of biosimilar rituximab in hematological cancers and inflammatory diseases.
Wojciech Jurczak, Stanley Cohen, Timothy M Illidge, Antonio da Silva, Jutta Amersdorffer

Future Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The management of primary mediastinal B-cell lymphoma: a British Society for Haematology Good Practice Paper.
Kate Cwynarski, Maria A V Marzolini, Sally F Barrington, George Follows, Timothy Illidge

Br J Haematol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of apoptosis imaging biomarkers in a genetic model of cell death.
Vessela Vassileva, Stephen M Stribbling, Chris Barnes, Laurence Carroll, Marta Braga, Timothy M Illidge

EJNMMI Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting the role of radiotherapy in Hodgkin lymphoma to augment systemic immunity.
Richard C Walshaw, Timothy M Illidge

Leuk Lymphoma· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group.
Andrea K Ng, Joachim Yahalom, Jayant S Goda, Louis S Constine, Chelsea C Pinnix, Timothy Illidge

Int J Radiat Oncol Biol Phys· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of radiation in the context of developing combination immunotherapies in cancer.
Jamie Honeychurch, Timothy M Illidge

Ther Adv Vaccines Immunother· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis